Head/Neck Cancer

Top Story

Multi-antigen T-Cell Infusion Against Neuro-oncologic Disease

Cell Therapy Next, May
Clinical Trials Snapshot

Intracerebral EGFR-vIII CAR T Cells for recurrent glioblastoma

Cell Therapy Next, May
Phase 1, open label, dose-escalation trial to determine the maximum tolerated dose of a novel, tumor-specific treatment with autologous EGFRvIII-CARs.
Clinical Trials Snapshot

Genetically modified T cells in treating patients with recurrent or refractory malignant glioma

Cell Therapy Next, May
Phase 1, open-label, interventional trial to determine the adverse effects and best dose of genetically modified T-cell immunotherapy in treating patients with relapsed…
In the JournalsPerspective

'Pressing need' for quality data on treatment options for low-risk thyroid cancers

May 18, 2020
Models projecting incidence of low-risk papillary thyroid cancers suggest there will be more than 200,000 new thyroid cancer diagnoses during the next 5 years, with at…
More Headlines »